AURA Biotechnologies Pvt. Ltd. is a Chennai-based biotechnology and healthcare company engaged in the research, development, manufacturing, and commercialization of innovative products across human diagnostics, veterinary diagnostics, medical devices, and agricultural biotechnology.

With established R&D and manufacturing capabilities, AURA focuses on translating biotechnology into practical, affordable, and scalable solutions for healthcare and allied sectors. The company has developed capabilities spanning rapid diagnostic technologies, molecular diagnostics, biomaterials, formulation development, manufacturing, quality control, and product commercialization.

A key strategic focus of AURA is the medical device segment, particularly hemostasis, bleeding control, advanced wound care, and wound management. The company is actively developing and expanding technologies intended for rapid hemorrhage control, emergency and trauma care, surgical applications, first-aid, defense and tactical medicine, and effective wound management.

AURA's work in this area includes chitosan-based hemostatic technologies and a broader vision to establish an integrated portfolio covering hemostatic dressings, advanced wound-care materials, wound management products, and related biomaterial-based medical devices.

Through a combination of in-house R&D, manufacturing infrastructure, regulatory capabilities, technology partnerships, and international collaborations, AURA aims to build a strong medical-device platform capable of serving the Indian as well as global healthcare markets, with particular emphasis on technologies that can improve bleeding control, wound healing, and patient outcomes.